ARCHIVES

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

This article is from The Cancer Letter archive.

Vol. 20 No. 21 | May 27, 1994

Download PDF Visit The Full Archive

Related Articles

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980

NCI Health Disparities Center Will Attempt To Influence Policy, Harold Freeman Says.

November 3, 2000

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976

Report From The Front Lines In War On Cancer Past, Present.

March 3, 2000